Explore Global Companies & Account Intelligence

regulanet® Switzerland is a networking group comprised of professionals from 14 European countries focused on establishing Quality Systems and Licenses for pharmaceutical companies. We specialize in assisting companies of all sizes to expand their business to the European Union while ensuring that their development plans are designed and implemented to receive licenses for the commercialization of their product in their chosen countries. Based in the center of Europe, regulanet® Switzerland will coordinate your expansion with local QM Systems and Licenses experts to provide you with a cost-effective and timely process, increasing your chances of success from the very beginning. We enjoy taking on ambitious projects and understanding your products challenges is the heart of what we do. Our network of professionals in 14 European countries will always work hard to develop innovative, tailored and cost-effective strategies based on your needs. If you have a question or are interested in any of our services, please contact us at: contact@regulanet.ch

Comprehensive enterprise dossier available in global intelligence registry.

Comprehensive enterprise dossier available in global intelligence registry.

R&Q exists to improve peoples lives; the patients, our clients and our team members. R&Q helps bring more safe and effective medical devices to market for both medical device companies and combination product companies. Leveraging our deep industry experience, our company provides solutions that help improve the world. Drawing on expertise across the entire medical device product lifecycle, R&Q is uniquely positioned to present a range of strategic and tactical options and execute on the solution that best suits our clients individual regulatory and quality needs. R&Qs headquarters are in Pittsburgh, PA with additional offices in Cleveland, OH, Boston, MA, Minneapolis, MN and Philadelphia, PA. From these offices, we service both nationally and internationally. R&Q is 100% women owned and is a certified Womens Business Enterprise by WBENC.

Regulatory Science Associates (RSA) is an expert consultancy group of highly qualified and reputable associate toxicologists and regulatory affairs specialists. An enthusiastic and committed group, we specialise in techno-regulatory support with particular focus on issues relating to human health which impact classification and labelling, hazard and risk assessment including DNEL derivation (REACH). Additionally, our group is expanding to include specialists from the Pharma industry (toxicology, safety pharmacology and pathology) with experience in pre-clinical development to support submissions of new medicines. RSA is also experienced in technical dossier compilation, in particular within the context of REACH and Plant Protection Product regulation. Our clients include blue chip companies, CROs and major European Consortia. We are located in the UK, based near Glasgow with associates in the Manchester and London areas. [ RSA is the trading name of Regulatory Science Ltd ]

At Regulus, we offer temporary, contract, temporary-to-permanent, and Business Analyst Career direct placements. So we can assist you in every stage of your employment. Check out our current openings on the career page for your next gig. If one is not available, ask a representative to assist you in newly available opportunities.

REGUM es una empresa de inversiones, dedicada a la investigación de los mercados financieros. Generamos contenido e información de calidad para ayudar en la toma de decisiones de los inversores locales e internacionales. Especialistas en inversiones alternativas. Miembros de la cámara FINTECH en Chile, Uruguay, Peru y Mexico. Registrados como Asesor de Inversiones ante la Comision para el Mercado Financiero - CMF - https://www.cmfchile.cl Información, educación y acceso a los mercados financieros.

Il più grande ecosistema tecnologico dedicato all’economia circolare. Forniamo un aiuto concreto alle persone economicamente fragili e aiutiamo le aziende ad essere più sostenibili.

Regxia is a unique scientific and regulatory consulting firm serving the pharmaceutical and biotech industries. At Regxia we strive to provide personalized attention focusing on your specific regulatory needs. We offer a full range of regulatory services to support your product at all stages of development, from concept to launch and throughout its lifecycle. We excel by taking a collaborative approach on every initiative, delivering high quality, customized solutions consistent with your corporate culture and the ever-evolving regulatory environment. Our in-depth awareness and understanding of global regulatory requirements allows us to outline appropriate regulatory strategies which minimize time to market. At Regxia we have one purpose: to ensure our clients’ success and we accomplish this by using the most innovative approaches in the industry. Regxia's team has the knowledge, experience and insight your business needs to achieve its regulatory objectives. Whether provided as part of overall project management or on a stand-alone basis, Regxia will advise on a full range of regulatory services including: scientific writing, strategic consulting, dossier publishing (eCTD), CMC, clinical, and post-approval support. Our clients are our primary focus. Proven Experience...Fresh Thinking! www.regxia.com info@regxia.com

Mit Enthusiasmus und einer Leidenschaft für gute Weine gründete Carl Reh im Jahr 1920 an der Mosel ein Handelsunternehmen für Trauben, Most und Wein. Wenige Jahre später baute er dort seine erste große Kellerei. Innovativ und stets auf beste Qualität bedacht, wuchs das Unternehmen zu einer der größten Kellereien Deutschlands. Der Zusammenschluss der Kellereien Carl Reh, Leiwen, und Hermann Kendermann, Bingen, machte die Reh Kendermann GmbH Weinkellerei zu einem der führenden Weinexporteure Deutschlands. Noch heute ist die Kellerei in Familienbesitz von Andrea und Carl Reh – mittlerweile in der dritten Generation. Carl Reh fühlt sich den Werten seines Großvaters, qualitativ hochwertigen Wein zu produzieren und zu vertreiben, verpflichtet. Reh Kendermann ist eine der modernsten Weinkellereien Deutschlands und führend in der Konzeption und Produktion von Markenweinen und Premium-Own-Label Produkten. Zum Markenportfolio zählt vor allem Black Tower, die erfolgreichste Weinmarke aus Deutschland mit aktuell ca. 14 Mio. verkauften Flaschen weltweit. Reh Kendermann vertreibt exklusiv die original gefüllten Marken Espiritu de Chile, Lindeman’s aus Australien sowie die italienischen Marke CANTI. Der Hauptsitz der Reh Kendermann GmbH Weinkellerei mit Geschäftsleitung, Vertrieb, Verwaltung, Kellerei, Abfüllung und Weinlager ist in Bingen angesiedelt, weitere Standorte finden sich in Leiwen, Gau-Bickelheim und Böchingen. Am Standort Oprisor, im Südwesten Rumäniens, stehen 252 Hektar Rebfläche im Ertrag. Im April 2017 hat die Reh Kendermann GmbH zudem das südafrikanische Weingut Napier Vineyards übernommen. www.reh-kendermann.de/impressum

reha VOR ORT is a medical practice company based out of 6 Bahnstr., Wiesbaden, Germany.

YouRehab and Reha-Stim Medtec are pleased to announce their merger under the new brand name REHA STIM MEDTEC. YouRehab, founded in 2010 as one of the first companies introducing sensor based game-like therapy in rehabilitation, has a wide range of knowledge in sensor based technology and the design of serious games. Reha-Stim Medtec has been founded in 1999 following the large clinical evidence of the well-known Prof. Dr. Stefan Hesse. It is the pioneer in end effector based robotic gait therapy and offers as well scientifically proven upper limb rehabilitation devices. Our joint forces will allow us to combine the latest clinical knowledge with advanced, easy-to-use technologies to create high impact rehabilitation devices. The symbiosis of the product portfolios will enable REHA STIM MEDTEC to offer a complete range of upper and lower limb training devices for all stages of the rehabilitation process. Clinically oriented easy-to-use product design combined with patient motivating feedback will be the center of our product strategy. The first results of our enhanced product strategy will be introduced at Medica 2017 in Dusseldorf. Visit our booth in Hall 4 B 44 to see the brand-new REHA STIM Gait Trainer GT2, the successor of the world’s first end effector based gait trainer GT1, and the brand-new REHA STIM Bi-Manu-Trainer, our sensor based solution for upper limb rehabilitation. Join us at Medica and learn more about the joint REHA STIM MEDTEC product portfolio.